L-tetrahydropalmatine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L-tetrahydropalmatine, covering 2020-04-07 to 2020-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity [NA]